Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Alliance Global Partners Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $2.2

Author: Benzinga Newsdesk | August 15, 2023 10:51am

Alliance Global Partners analyst Ben Haynor maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $3.25 to $2.2.

Posted In: NMTC